Neuroblastic Tumor — Trials

Neuroblastic Tumor — Trials · CancerIndex

Clinical trials

Registered studies

619 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 137
Recruiting: 75
Ph III recruiting: 8
Growth YoY: −28%
Industry share: 8%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (80)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00582608	Tumor Detection Using Iodine-131-Labeled Monoclonal Antibody 8H9	terminated	N/A	12	Memorial Sloan Kettering Cancer CenterOTHER	1	Mar 1, 2017	clinicaltrials
NCT00946283	Lactobacillus in Preventing Infection in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Myelodysplastic Syndrome	terminated	N/A	30	Rutgers, The State University of New JerseyOTHER	1	Feb 3, 2017	clinicaltrials